Clinical Trial Update: A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

BL-M02D1 is undergoing a Phase 1/2 study in locally advanced or metastatic non-small cell lung cancer and other solid tumors. The sponsor is Sichuan Baili Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BL-M02D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING